The cost of Wegovy is not included in the cost of Weight Care+
Interestingly, Wegovy, another brand of Semaglutide used for weight control, ranked 10th with Q1 sales of DKK 17.36 billion (~$2.4 billion), up 85% YoY
Vernoux T, Wilson RC, Seeley KA
The drug was first studied for its potential to treat muscle-wasting conditions, such as those seen in patients with chronic illnesses like cancer or muscular dystrophy
Over 29 days of treatment, the peptide inhibited pulmonary artery muscularization (the thickening and stiffening of pulmonary arteries that drives this condition), prevented right heart hypertrophy (the enlargement of the right ventricle that occurs when it has to pump against increased resistance), and significantly decreased mortality
SUMMARY [0007] In view of this, the present invention provides a method for preparing Semaglutide